Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective studyPaola Faverio, Paola Rebora, Emanuela Rossi et al.|Internal and Emergency Medicine|2023Cited by 11
Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65 YearsAndrea Calcagno, Paola Pignata, Caterina Candela et al.|Open Forum Infectious Diseases|2025Cited by 0